As SEMA4D is highly expressed in HNSCC cells, Basile and colleagues silenced SEMA4D gene expression and found that vascularization of HNSCC tumor xenografts was dramatically decreased [43]. The gene discussed is SEMA4D; the disease is neoplasm.